COVID-19 and outpatient parenteral antimicrobial therapy: The need to protect vulnerable medicare beneficiaries

Yasir Hamad; Karen E. Joynt Maddox; William G. Powderly

doi:10.7326/M20-1774

COVID-19 and outpatient parenteral antimicrobial therapy: The need to protect vulnerable medicare beneficiaries

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	383-384
Number of pages	2
Journal	Annals of internal medicine
Volume	173
Issue number	5
DOIs	https://doi.org/10.7326/M20-1774
State	Published - Sep 1 2020

Access to Document

10.7326/M20-1774

Cite this

@article{911252f79bd540cfa831fc0f2e44244f,

title = "COVID-19 and outpatient parenteral antimicrobial therapy: The need to protect vulnerable medicare beneficiaries",

author = "Yasir Hamad and \{Joynt Maddox\}, \{Karen E.\} and Powderly, \{William G.\}",

note = "Funding Information: Financial Support: Dr. Joynt Maddox receives research support from the National Heart, Lung, and Blood Institute (R01HL143421) and National Institute on Aging (R01AG060935). Dr. Powderly was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health.",

year = "2020",

month = sep,

day = "1",

doi = "10.7326/M20-1774",

language = "English",

volume = "173",

pages = "383--384",

journal = "Annals of internal medicine",

issn = "0003-4819",

number = "5",

}

TY - JOUR

T1 - COVID-19 and outpatient parenteral antimicrobial therapy

T2 - The need to protect vulnerable medicare beneficiaries

AU - Hamad, Yasir

AU - Joynt Maddox, Karen E.

AU - Powderly, William G.

N1 - Funding Information: Financial Support: Dr. Joynt Maddox receives research support from the National Heart, Lung, and Blood Institute (R01HL143421) and National Institute on Aging (R01AG060935). Dr. Powderly was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health.

PY - 2020/9/1

Y1 - 2020/9/1

UR - https://www.scopus.com/pages/publications/85090169616

U2 - 10.7326/M20-1774

DO - 10.7326/M20-1774

M3 - Comment/debate

C2 - 32422072

AN - SCOPUS:85090169616

SN - 0003-4819

VL - 173

SP - 383

EP - 384

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 5

ER -

COVID-19 and outpatient parenteral antimicrobial therapy: The need to protect vulnerable medicare beneficiaries

Access to Document

Other files and links

Cite this